Followers | 145 |
Posts | 27561 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Tuesday, January 26, 2021 11:34:29 AM
Are you kidding? You know what the mc is today?
Market Cap 1.737B
Since you introduced me to this company it has doubled
in price, if it was richly valued then, what is it now?
But this is besides my previous point - namely i 'missed'
the entry point.
Recent RYTM News
- Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology • GlobeNewswire Inc. • 04/29/2024 10:30:00 PM
- Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 • GlobeNewswire Inc. • 04/24/2024 08:01:00 PM
- Rhythm Pharmaceuticals Announces New Employment Inducement Grants • GlobeNewswire Inc. • 04/16/2024 08:01:00 PM
- Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Rhythm Pharmaceuticals Announces New Employment Inducement Grants • GlobeNewswire Inc. • 03/11/2024 08:01:00 PM
- Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences • GlobeNewswire Inc. • 03/06/2024 09:01:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/29/2024 09:58:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:46:06 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/29/2024 09:44:28 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 09:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 12:01:26 PM
- Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan • GlobeNewswire Inc. • 02/22/2024 12:01:00 PM
- Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update • GlobeNewswire Inc. • 02/22/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:02:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:01:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:00:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:00:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 11:14:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 01:49:16 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 01:47:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 01:46:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 01:45:18 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/09/2024 09:19:15 PM
- Rhythm Pharmaceuticals Announces New Employment Inducement Grants • GlobeNewswire Inc. • 02/08/2024 09:01:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM